Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.53 CHF | +1.19% | -0.66% | +0.78% |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 18 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.78% | 203B | |
+25.06% | 672B | |
+24.08% | 550B | |
-6.30% | 351B | |
+15.19% | 317B | |
+7.30% | 292B | |
+3.26% | 211B | |
-10.37% | 144B | |
-7.29% | 141B | |
-3.20% | 113B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- US FDA Delays Action On Novartis Partner's Biologics License Application For Tislelizumab